# Synaptic control of retinal ganglion cell survival and axon regeneration

**Authors:** Yuxuan Qiu, Qi Zhang, Jiahui Tang, Yunjie Cheng, Yuxin Wang, Zijie Wang, Xuehan Liu, Bing Zhang, Liyan Liu, Shilong Yu, Yangjiani Li, Zhe Liu, Fang Chai, Yehong Zhuo, Yiqing Li

PMC · DOI: 10.1186/s13024-026-00929-1 · 2026-01-28

## TL;DR

This paper reviews how retinal synapses influence the survival and regeneration of retinal ganglion cells after injury, suggesting new strategies for treating vision loss.

## Contribution

The paper highlights the novel role of synaptic communication in regulating retinal ganglion cell survival and regeneration after injury.

## Key findings

- Retinal interneuron-to-RGC synaptic connections are structurally and molecularly dysregulated after injury.
- Synaptic plasticity regulates RGC survival and regenerative capacity by orchestrating intrinsic repair programs.
- The role of glial cells in transsynaptic dysregulation remains an unresolved question.

## Abstract

Injury to retinal ganglion cell (RGC) axons in neurodegenerative conditions like glaucoma leads to irreversible vision loss. A major therapeutic challenge is promoting RGC survival and axon regeneration. Canonical research focused on intrinsic neuronal growth capacity and the inhibitory central nervous system (CNS) environment, but overlooking the role of retinal synaptic communication.

This review summarizes emerging evidence that retinal interneuron-to-RGC synaptic connections are both structurally and molecularly dysregulated following RGC axon injury. Such synaptic plasticity critically regulates RGC survival and regenerative capacity, at least partly by orchestrating intrinsic repair programs. We then address two central unresolved questions: first, what are the specific molecular pathways that alter this interneuron-to-RGC signaling after injury, and second, how do glial cells participate in this transsynaptic dysregulation. Finally, we evaluate the translational potential of these findings, including the identification of biomarkers and the development of novel neuroprotective strategies that target synaptic connections.

Synaptic communication is a fundamental regulator of RGC fate after injury. Understanding synaptic dysregulation and the mechanisms involved is essential for developing new synapse-targeted strategies to monitor progression of neurodegenerative diseases and promote neural repair.

## Linked entities

- **Diseases:** glaucoma (MONDO:0005041)

## Full-text entities

- **Genes:** SLC1A1 (solute carrier family 1 member 1) [NCBI Gene 6505] {aka DCBXA, EAAC1, EAAT3, SCZD18, hEAAC1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CD247 (CD247 molecule) [NCBI Gene 919] {aka CD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, IMD25}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, SLC18A2 (solute carrier family 18 member A2) [NCBI Gene 6571] {aka PKDYS2, SVAT, SVMT, VAT2, VMAT2}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, FAAH (fatty acid amide hydrolase) [NCBI Gene 2166] {aka FAAH-1, FAAH1, PSAB}, PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, ACCS (1-aminocyclopropane-1-carboxylate synthase homolog (inactive)) [NCBI Gene 84680] {aka ACS, PHACS}, GPC4 (glypican 4) [NCBI Gene 2239] {aka K-glypican, KPTS}, NPY (neuropeptide Y) [NCBI Gene 4852] {aka PYY4}, FBXW4 (F-box and WD repeat domain containing 4) [NCBI Gene 6468] {aka DAC, FBW4, FBWD4, SHFM3, SHSF3}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, OPN4 (opsin 4) [NCBI Gene 94233] {aka MOP}, Nos (Nitric oxide synthase) [NCBI Gene 34495] {aka CG6713, DNOS, DNOS1, Dmel\CG6713, NOS1, NOS2}, GPC6 (glypican 6) [NCBI Gene 10082] {aka OMIMD1}, LIN28A (lin-28 RNA binding posttranscriptional regulator A) [NCBI Gene 79727] {aka CSDD1, LIN-28, LIN28, ZCCHC1, lin-28A}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, MAP3K12 (mitogen-activated protein kinase kinase kinase 12) [NCBI Gene 7786] {aka DLK, HP09298, MEKK12, MUK, ZPK, ZPKP1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, DRD1 (dopamine receptor D1) [NCBI Gene 1812] {aka D1R, DADR, DRD1A}, CRIPTO3 (cripto, EGF-CFC family member 3) [NCBI Gene 6998] {aka CR-3, CRIPTO-3, TDGF1, TDGF1P3, TDGF2, TDGF3}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, CTBP2 (C-terminal binding protein 2) [NCBI Gene 1488], NTRK2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 4915] {aka DEE58, EIEE58, GP145-TrkB, OBHD, TRKB, trk-B}, DDIT4L (DNA damage inducible transcript 4 like) [NCBI Gene 115265] {aka REDD2, Rtp801L}, SPARCL1 (SPARC like 1) [NCBI Gene 8404] {aka MAST 9, MAST9, PIG33, SC1}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, SLC1A3 (solute carrier family 1 member 3) [NCBI Gene 6507] {aka EA6, EAAT1, GLAST, GLAST1}, SLC30A3 (solute carrier family 30 member 3) [NCBI Gene 7781] {aka ZNT3}
- **Diseases:** epilepsy (MESH:D004827), Amyotrophic lateral sclerosis (MESH:D000690), ischemia-reperfusion injury (MESH:D015427), RGC degeneration (MESH:D012162), RGC (MESH:D012173), peripheral and central nervous system disorders (MESH:D010523), glaucoma (MESH:D005901), RGC damage (MESH:D012164), axon degeneration (MESH:D009410), depression (MESH:D003866), OHT (MESH:D009798), central retinal artery occlusion (MESH:D015356), Axon injury (MESH:D001480), ALS (MESH:D008113), Blinding Eye Diseases (MESH:D005128), impairment of visual function (MESH:D014786), Parkinson's disease (MESH:D010300), injury (MESH:D014947), neurodegeneration (MESH:D019636), disease (MESH:D004194), ONI (MESH:D020221), optic nerve crush (MESH:D000080344), optic neuropathies (MESH:D009901), traumatic brain injury (MESH:D000070642), CNS disorders (MESH:D002493), neurotoxic (MESH:D020258), ischemic (MESH:D002545), damage (MESH:D020263), blindness (MESH:D001766), ischemia (MESH:D007511), open-angle glaucoma (MESH:D005902), GCL (MESH:D007965), SCI (MESH:D013119), dendritic degeneration (MESH:D007635)
- **Chemicals:** Na+ (MESH:D012964), Ca2+ (-), L-DOPA (MESH:D007980), aspartate (MESH:D001224), Lipid (MESH:D008055), Endocannabinoid (MESH:D063388), serotonin (MESH:D012701), Calcium (MESH:D002118), reactive oxygen species (MESH:D017382), DA (MESH:D004298), PS (MESH:D010758), Zinc (MESH:D015032), cGMP (MESH:D006152), memantine (MESH:D008559), NO (MESH:D009569), excitatory amino acids (MESH:D018846), glycine (MESH:D005998), GABA (MESH:D005680), N-methyl-D-aspartic acid (MESH:D016202), Glutamate (MESH:D018698), anandamide (MESH:C078814)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Rodentia (rodent, order) [taxon 9989], Cricetinae (hamsters, subfamily) [taxon 10026], Homo sapiens (human, species) [taxon 9606], Drosophila melanogaster (fruit fly, species) [taxon 7227], Petrachloros mirabilis (species) [taxon 2918835], Carassius auratus (goldfish, species) [taxon 7957]
- **Cell lines:** RPE — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924416/full.md

---
Source: https://tomesphere.com/paper/PMC12924416